| CRSP | 10.06% | 56.80 | -3.73% | 2,056,918 | |
| TEM | 8.52% | 56.88 | -4.56% | 1,520,030 | |
| TWST | 7.45% | 38.03 | -1.14% | 2,089,148 | |
| GH | 6.27% | 50.25 | -2.03% | 1,319,170 | |
| RXRX | 5.64% | 5.28 | -7.52% | 11,438,290 | |
| NTRA | 5.03% | 160.43 | -1.79% | 328,963 | |
| PSNL | 4.94% | 6.370 | -7.95% | 6,953,838 | |
| ADPT | 4.11% | 11.820 | -2.15% | 3,779,147 | |
| TXG | 3.99% | 12.80 | +1.43% | 3,239,403 | |
| SDGR | 3.80% | 21.01 | -3.22% | 1,916,981 |
ARK ETF Trust - ARK Genomic Revolution ETF is an exchange traded fund launched and managed by ARK Investment Management LLC. It invests in public equity markets of global region. The fund invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund invests in stocks of companies that are deemed socially conscious in their business dealings and directly promote environmental responsibility. The fund employs fundamental and quantitative analysis with bottom-up and top-down stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the NASDAQ Healthcare Index, the S&P 500 Index and the MSCI World Index. The fund employs internal and external research to create its portfolio. ARK ETF Trust - ARK Genomic Revolution ETF was formed on October 31, 2014 and is domiciled in the United States.